News on ten23
Science that disrupts
Our journey at ten23 health is driven by collaboration, innovation, and purpose for the benefit of Patients, People, and Planet.
In this space, we bring together stories from the media, insights from our partners, and voices from our customers — all reflecting the impact we make together in advancing high-quality, sustainable medicines.
Press Articles
2026 March - Technology Training Center by Glatt GmbH: Process Analytical Technology, or PAT, has long been established in many companies, at least in name. Yet in broad industrial application, much of its potential remains untapped. In conversation with Hanns Christian Mahler, CEO and Co Founder of ten23.health, it quickly becomes clear where PAT reaches its practical limits.
2026 February - Pharmaceutical Research by Springer: Lyophilization is a promising strategy to enhance the long-term stability of messenger RNA lipid nanoparticles (mRNA-LNPs). However, lyophilization-induced stresses can impact product quality and the underlying mechanisms remain poorly understood.Read the study co-authored by our colleagues Andrea Allmendinger, Andrei Hutanu and Hanns-Christian Mahler.
2026 January - BioProcess International - eBook: Outsourcing — Strengthening Partnerships Between Contract Organizations and Drug Developers. Partnering with contract development and manufacturing organizations (CDMOs) does not simply entail the use of their equipment; such companies also offer portfolios of expertise for candidate selection, supply-chain management, and regulatory activities. This eBook explores the different services that contract organizations can provide and how sponsors can lean on them for support - with a special feature on ten23 health.
2025 December - GEN - Genetic Engineering & Biotechnology News: In this article our colleagues Andrea Allmendinger and Hanns-Christian Mahler explore the essential role of primary packaging materials in parenteral drug development and manufacturing.
2025 December - International Journal of Pharmaceutics: Read the scientific article on the topic fogging and its impact on container closure integrity in the example of a lyophilized drug product, authored by our colleagues Andrea Allmendinger and Hanns-Christian Mahler.
2025 November - PharmTech.com: Watch this interview and learn how advances in patient-centric drug delivery are transforming ten23 health's development strategies as a next-generation CDMO.
2025 October - PharmExec.com: The Situation We Faced: Risk Assessment of Failure Modes and Partners Understanding of Risk in Fill-Finish - a video interview with Hanns-Christian Mahler, hosted by Chris Spivey, on decision-making in manufacturing, focusing on risk management, packaging challenges, and strategies for product safety and quality.
2025 October - The Pharma Navigator: Avoiding Manufacturing Failures with Integrated Planning - video interview with Hanns-Christian Mahler from ten23 health.
2025 September - The Medicine Maker: In this eBook, we celebrate sustainability. We look at how CDMOs can be more sustainable, as well as discussing packaging, logistics, and clinical trials. Featuring ten23 health!
2025 September - The Pharma Navigator: Making the Right Capacity Decisions at the Biomanufacturing Crossroads. Read on ten23 health's capabilities for biopharmaceutical drug products, and how we qualify as a reliable partner in the current times.
2025 August - The Pharma Navigator: Unpacking the Cost of Biomanufacturing - find out the role that ten23 health plays in the global market.
2025 July - BioProcess International: Mastering Protein Stability in Injectable Biopharmaceuticals: Five Keys to Success: by Andrea Allmendinger, Michael Adler, and Hanns-Christian Mahler
2025 July - PharmaBoardRoom: Interview with Hanns-Christian Mahler, CEO ten23 health: "We want to be remembered not just for growth — but for setting a new standard in how CDMOs work and lead"
2025 July - PharmTech.com: Flexibility Provides Solutions to Small-Batch Manufacturing Challenges - article featuring ten23's approach for small-batch fill&finish solutions.
2025 June - Drug & Device World: Swiss CDMO ten23 health’s CEO talks about challenges in sustainability reporting and his approach to environmental sustainability.
2025 June - Drug Development & Delivery: SPECIAL FEATURE- Outsourcing Formulation Development & Manufacturing: CDMOs Are Making Their Supply Chains More Resilient & Secure - with the participation of ten23 health,
2025 April - The Medicine Maker: Predictions for Pharma's future, read Hanns-Christian's answer about the disruptions in 5-10 years in the pharmaceutical industry.
2025 April - Newsweek: A personal interview with our CEO Hanns-Christian Mahler in the Investment Reports of the Newsweek.
2025 March - Pharma Manufacturing: Pharma Predictions 2025: From manufacturing to supply chain strategies, here’s how drug manufacturers are looking at the year ahead. With Hanns-Christian Mahler, CEO ten23 health,
2025 March - BioSpectrum: CDMOs like ten23 health are adopting sustainable practices by utilising single-use bioreactors, continuous flow manufacturing, and biocatalysis to reduce waste and enhance efficiency.
2025 January - Elsevier: In this article, Anna Ruppl, Denis Kiesewetter, Monika Köll-Weber, Thomas Lemazurier, Regine Süss and Andrea Allmendinger elaborate about Lipid nanoparticles (LNPs) that have demonstrated their therapeutic potential as safe and effective drug delivery systems for nucleic acids during the COVID-19 pandemic.
2025 January - On Drug Delivery Magazine: In this article, Andrea Allmendinger, PhD, Chief Scientific Officer,Dr. Nicolas Brandes and Hanns-Christian Mahler, PhD, Chief Enablement Officer, all at ten23 health discuss the device selection: Injection volumes for subcutaneous administration.
2024 December - The Manufacturing Chemist: Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain - read on the ten23 health approach.
2024 September - BioPharmInternational: Interview with Hanns-Christian Mahler, CEO of ten23 health, about his work in the bio/pharma industry and what he sees for the industry’s future.
2024 September - On Drug Delivery Magazine: In this article, Andrea Allmendinger, PhD, Chief Scientific Officer, Michael Adler, PhD, Director Drug Product Design, Carole Delauney, Senior Director Business Development, and Hanns-Christian Mahler, PhD, Chief Enablement Officer, all at ten23 health, provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
2024, June -Drug Development & Delivery Magazine: ten23 health: Leveraging Technology & Humans to Balance Development – Page 50 of Special Issue in Outsourcing Companies.
2024, May - On Drug Delivery Magazine: In this article, Alissa Monk, Fairstainability Co-Circle Lead at ten23 health, Kami Krista, Chief Executive Officer and Co-Founder of Elio, Cédric Montagne, Sustainability Strategy, Reporting and Engagement, and Carole Schanté, PhD, Fairstainability Co-Lead, both of ten23 health, explore the potential of artificial intelligence and big data in eco-design with the aim of transforming the pharmaceutical industry towards greater sustainability.
2024, May - On Drug Delivery Magazine: Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post launch, especially when transferring from a vial format for intravenous infusion. Pages 08 to 14.
2024, March - On Drug Delivery Magazine: Andrea Allmendinger, Philipp Behrendt and Hanns-Christian Mahler present the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.
2024, February - Pharmaceutical Technology: Andrea Allmendinger and Hanns-Christian Mahler present two case studies to illustrate the complexity of modern sterile product developments.
2024, February - Europe's Pioneering Leaders Shaping the Future of Healthcare. In this article, Euro Health Leaders Magazine features a portrait of ten23 health's CEO & Founder Prof. Dr. Hanns-Christian Mahler.
2024, February - ten23 health: Sustainable success. With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines.
2023, May - Intravitreal Injections - more than meets the eye: In this article, Andrea Allmendinger and Hanns-Christian Mahler highlight the technical challenges of intravitreal administration and considerations from the ophthalmologist’s and patient’s perspectives.
2023, March - Integrated Drug Product - Development and Manufacturing. Here, Andrea Allmendinger, Michael Adler and Hanns-Christian Mahler, all at ten23 health, highlight the importance of integrated drug product development, considering aspects such as formulation, device, container closure system, manufacturing processes and usability.
2023, February - Andrea Allmendinger and Hanns-Christian Mahler, talking about challenges in the commercialization of pre-filled syringes and injection devices.
2022 - Andrea Allmendinger and Hanns-Christian Mahler, talking about “How ten23 health is meeting developmental challenges for intravitreal products”.
2022, June - Hanns-Christian Mahler and Rainer Glöckler are talking about “Automating Aseptic Processing reduces Contamination Risk” in Pharmaceutical Technology.
2022, May - Susanne Jörg, our COO is talking about the relevance of Drug Product development and manufacturing for Biologics.
2022, April - Addressing the Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery.
2021, April - On “State-of-the-art solutions for ophthalmic sterile drug product manufacturing” with Rainer Glöckler and Carole Delauney.
Podcasts
2026. January: The Leadership Learns Podcast: Hear about ten23 health's mission, which goes beyond developing pharmaceutical solutions; it’s about building a company where sustainability, culture, and mindset are as integral as technical excellence.
2025. December: ARTO Talent Podcast: What does it really take to build one of Europe’s fastest-growing drug-product CDMOs, and do it with scientific precision, culture-first leadership, and a B-Corp mindset?
2025. August:Through the Line Podcast: Tracing The Tracks of the Drug and Medical Device Trail - in this episode you will find out more about track and trace for sterile drug product containers and how ten23 health partners with BD and their new product BD idFill, using RFID technology for pre-filled syringes.
2025. February: Listen to Kymanox Executive Advisor, Mathias Romacker, for an insightful conversation with industry pioneer Hanns-Christian Mahler, our Founder and CEO , as they explore the evolution of biologics drug delivery and CDMO services. From prefilled syringes to large-volume subcutaneous administration, discover how ten23 health is revolutionizing sterile fill-finish capabilities and combination product development.
2024. December: Hanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.
2024, October: We are happy to be featured in the latest CPHI issue by Pharmaceutical Technology, where we had the opportunity to discuss the fill/finish market and sustainability considerations for facilities. Listen to the podcast interview conducted by Felicity Thomas with our CEO Hanns-Christian Mahler.
2024, September: Listen to the interview in the Brightroom Podcast with Hanns-Chrsitian Mahler and Felicia Werk on how it is to work at ten23 and our company culture.
2024, June: Tune in to learn with our CEO Hanns-Christian Mahler on the current growth and advancements in pharmaceutical Fill/Finish, with a re-freshing interview conducted by Felicity Thomas.
2024, May: Listen to the first radio interview of Hanns-Christian Mahler in celebration of the World Laboratory Day in 2024, broadcasted through 175 radio stations in the United Kingdom!
2024, March: In this episode, Lori-Ann Duguay interviews Hanns-Christian Mahler, CEO of ten23 Health, about their unique approach to organizational culture.
2023, October: Hanns-Christian Mahler (CEO ten23 health) interviewed by Uwe Techt, in his podcast series 'Leverage Business! Das nachhaltig wachsende Unternehmen in Mittelstand' - German only
2023, May: Hanns-Christian Mahler (CEO ten23 health) and Andrea Allmendinger (CSO ten23 health) talk about Biologic Drug Development and Manufacturing on this episode of Drug Solutions Podcast.
2022, February: Hanns-Christian Mahler talking with Raman Seghal in the Molecule to Market podcast
Books
Inner Development Goals
At a time when the world demands profound change, transformation begins within. As part of a two-volume work, this first volume explores the personal journeys that fuel collective leadership, weaving together research, art, case studies, and practices from the global Inner Development Goals (IDG) community. Our colleagues Hanns-Christian Mahler and Felicia Werk contributed as authors of one of the book chapters.
Reinventing Organizations ten23 health's DNA relies in many aspects of the book by Frederic Laloux's Reinventing Organizations. The book is considered by many to be the most influential management book of the last decade. It has inspired thousands of organizations throughout the world to take a radical leap and adopt a whole different set of management principles and practices.
The Loop Approach®
The foundational governance of ten23 health is based on the methodology The Loop Approach®. It provides a clear process for transformation initiatives and yet remains open enough to accommodate the specific needs of an organization.
Customer Feedback on our Swiss Quality Services
Technical knowledge, expertise, and skills; proactive communication, excellent presentations and explanations/clarifications, prompt completion of tasks, always within scheduled timelines, willingness to adjust and adapt work efforts as needed and in a timely manner.
CEO, Biotech
We really appreciate the collaborative atmosphere of working with ten23. While the ten23 technical team is highly knowledgeable, logical in their thinking, and decisive in their decision making, we have found the ten23 team to be very accommodating in their willingness/openness to discuss alternatives and work together to identify the best solution that is mutually acceptable to both parties. This is invaluable to us and we believe your team excels at this.
(This is not always the case with even some of the "best" contract manufacturers. I am sure this is true for many customers as well).
Project Lead, Top-Ten Pharma
The ten23 team did an excellent job of running the study to a very high quality and delivering fully qualified data to us on time. I was really impressed with how seamlessly this was managed without any hiccups. I am happy to work with such a great team that knows how to meet expectations and deliver high quality performance.
A big bow!
Project Lead, Top-Ten Pharma